Skip to main content

Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?

Publication ,  Conference
Sadot, E; Groot Koerkamp, B; Leal, JN; Shia, J; Gonen, M; Allen, PJ; DeMatteo, RP; Kingham, TP; Kemeny, N; Blumgart, LH; Jarnagin, WR; DʼAngelica, MI
Published in: Ann Surg
September 2015

OBJECTIVES: The impact of margin width on overall survival (OS) in the context of other prognostic factors after resection for colorectal liver metastases is unclear. We evaluated the relationship between resection margin and OS utilizing high-resolution histologic distance measurements. METHODS: A single-institution prospectively maintained database was queried for all patients who underwent an initial complete resection of colorectal liver metastases between 1992 and 2012. R1 resection was defined as tumor cells at the resection margin (0 mm). R0 resection was further divided into 3 groups: 0.1 to 0.9 mm, 1 to 9 mm, and 10 mm or greater. RESULTS: A total of 4915 liver resections were performed at Memorial Sloan Kettering Cancer Center between 1992 and 2012, from which 2368 patients were included in the current study. Half of the patients presented with synchronous disease, 43% had solitary metastasis, and the median tumor size was 3.4 cm. With a median follow-up for survivors of 55 months, the median OS of the R1, 0.1 to 0.9 mm, 1 to 9 mm, and 10 mm or more groups was 32, 40, 53, and 56 months, respectively (P < 0.001). Compared with R1 resection, all margin widths, including submillimeter margins correlated with prolonged OS (P < 0.05). The association between the margin width and OS remained significant when adjusted for all other clinicopathologic prognostic factors. CONCLUSIONS: Resection margin width is independently associated with OS. Wide margins should be attempted whenever possible. However, resection should not be precluded if narrow margins are anticipated, as submillimeter margin clearance is associated with improved survival. The prolonged OS observed with submillimeter margins is likely a microscopic surrogate for the biologic behavior of a tumor rather than the result of surgical technique.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Ann Surg

DOI

EISSN

1528-1140

Publication Date

September 2015

Volume

262

Issue

3

Start / End Page

476 / 485

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Survival Analysis
  • Surgery
  • Statistics, Nonparametric
  • Risk Assessment
  • Retrospective Studies
  • Proportional Hazards Models
  • New York City
  • Neoplasm Invasiveness
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Sadot, E., Groot Koerkamp, B., Leal, J. N., Shia, J., Gonen, M., Allen, P. J., … DʼAngelica, M. I. (2015). Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? In Ann Surg (Vol. 262, pp. 476–485). United States. https://doi.org/10.1097/SLA.0000000000001427
Sadot, Eran, Bas Groot Koerkamp, Julie N. Leal, Jinru Shia, Mithat Gonen, Peter J. Allen, Ronald P. DeMatteo, et al. “Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?” In Ann Surg, 262:476–85, 2015. https://doi.org/10.1097/SLA.0000000000001427.
Sadot E, Groot Koerkamp B, Leal JN, Shia J, Gonen M, Allen PJ, et al. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? In: Ann Surg. 2015. p. 476–85.
Sadot, Eran, et al. “Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate?Ann Surg, vol. 262, no. 3, 2015, pp. 476–85. Pubmed, doi:10.1097/SLA.0000000000001427.
Sadot E, Groot Koerkamp B, Leal JN, Shia J, Gonen M, Allen PJ, DeMatteo RP, Kingham TP, Kemeny N, Blumgart LH, Jarnagin WR, DʼAngelica MI. Resection margin and survival in 2368 patients undergoing hepatic resection for metastatic colorectal cancer: surgical technique or biologic surrogate? Ann Surg. 2015. p. 476–485.

Published In

Ann Surg

DOI

EISSN

1528-1140

Publication Date

September 2015

Volume

262

Issue

3

Start / End Page

476 / 485

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Time Factors
  • Survival Analysis
  • Surgery
  • Statistics, Nonparametric
  • Risk Assessment
  • Retrospective Studies
  • Proportional Hazards Models
  • New York City
  • Neoplasm Invasiveness